Combination of a phosphoinositide 3kinase inhibitor and an antidiabetic compound

Details for Australian Patent Application No. 2010247397 (hide)

Owner Novartis AG

Inventors Baselga, Jose; Di Cosimo, Serena; Garcia-Echeverria, Carlos; Hackl, Wolfgang; Maira, Sauveur-Michel; Russillo, Michelangelo; Serra Elizalde, Violeta

Agent Davies Collison Cave

Pub. Number AU-B-2010247397

PCT Pub. Number WO2010/130779

Priority 09160440.5 15.05.09 EP

Filing date 12 May 2010

Wipo publication date 18 November 2010

Acceptance publication date 12 July 2012

International Classifications

A61K 31/155 - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/426 - 1,3-Thiazoles

A61K 31/427 - not condensed and containing further heterocyclic rings

A61K 31/437

A61K 31/4439

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 Drugs for disorders of the metabolism

A61P 35/00 Antineoplastic agents

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/130779 Priority application(s): WO2010/130779

12 July 2012 Application Accepted

  Published as AU-B-2010247397

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247398-Aqueous polymer dispersions

2010247394-Use of delta-tocopheryl-carbohydrate as a depigmenting agent